Literature DB >> 10456919

Preliminary characterization of a Mycobacterium abscessus mutant in human and murine models of infection.

T F Byrd1, C R Lyons.   

Abstract

The ability to persist in the host after the establishment of infection is an important virulence determinant for mycobacteria. Mycobacterium abscessus is a rapidly growing mycobacterial species which causes a variety of clinical syndromes in humans. We have obtained a rough, wild-type human clinical isolate of M. abscessus (M. abscessus-R) and a smooth, attenuated mutant (M. abscessus-S) which spontaneously dissociated from the clinical isolate. We have found that M. abscessus-R is able to persist and multiply in a murine pulmonary infection model in contrast to M. abscessus-S, which is rapidly cleared. To understand the basis for this difference, we characterized the behavior of these variants in human tissue culture models of infection. M. abscessus-R is able to persist and multiply in human monocytes, while M. abscessus-S is deficient in this ability. Both of these variants are phagocytized by human monocytes. M. abscessus-R resides in a phagosome typical for pathogenic mycobacteria with a tightly adherent phagosomal membrane. In contrast, M. abscessus-S resides in a "loose" phagosome with the phagosomal membrane separated from the bacterial cell wall. Both M. abscessus variants also have distinctive growth patterns in a recently described fibroblast-mycobacterium microcolony assay, with M. abscessus-R exhibiting growth characteristics similar to those previously reported for virulent M. tuberculosis and M. abscessus-S exhibiting growth characteristics similar to those previously reported for avirulent M. tuberculosis. In both the monocyte infection assay and the murine pulmonary infection model, numerous infected mononuclear phagocyte aggregates develop at sites of M. abscessus-R infection, but are absent with M. abscessus-S infection. We conclude that a mutation has occurred in the M. abscessus-S variant which has altered the ability of this organism to persist and multiply in host cells and that this may be related to the phenotypic changes we have observed in our tissue culture models of infection.

Entities:  

Mesh:

Year:  1999        PMID: 10456919      PMCID: PMC96797     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Pathogenicity of transparent, opaque, and rough variants of Mycobacterium avium in chickens and mice.

Authors:  W B Schaefer; C L Davis; M L Cohn
Journal:  Am Rev Respir Dis       Date:  1970-10

2.  Isolation and expression of a gene cluster responsible for biosynthesis of the glycopeptidolipid antigens of Mycobacterium avium.

Authors:  J T Belisle; L Pascopella; J M Inamine; P J Brennan; W R Jacobs
Journal:  J Bacteriol       Date:  1991-11       Impact factor: 3.490

3.  Chemical basis of rough and smooth variation in mycobacteria.

Authors:  J T Belisle; P J Brennan
Journal:  J Bacteriol       Date:  1989-06       Impact factor: 3.490

4.  Differential growth characteristics and streptomycin susceptibility of virulent and avirulent Mycobacterium tuberculosis strains in a novel fibroblast-mycobacterium microcolony assay.

Authors:  T F Byrd; G M Green; S E Fowlston; C R Lyons
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

5.  Infection with Mycobacterium avium complex in patients without predisposing conditions.

Authors:  D S Prince; D D Peterson; R M Steiner; J E Gottlieb; R Scott; H L Israel; W G Figueroa; J E Fish
Journal:  N Engl J Med       Date:  1989-09-28       Impact factor: 91.245

6.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.

Authors:  V Kindler; A P Sappino; G E Grau; P F Piguet; P Vassalli
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

7.  Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium.

Authors:  C Frehel; C de Chastellier; T Lang; N Rastogi
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

8.  Systemic Mycobacterium kansasii infection and regulation of the alloantigenic response.

Authors:  F M Collins; D S Cunningham
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

9.  The effect of phenolic glycolipid-1 from Mycobacterium leprae on the antimicrobial activity of human macrophages.

Authors:  M A Neill; S J Klebanoff
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

10.  Density of newly synthesized plasma membrane proteins in intracellular membranes. I. Stereological studies.

Authors:  G Griffiths; G Warren; P Quinn; O Mathieu-Costello; H Hoppeler
Journal:  J Cell Biol       Date:  1984-06       Impact factor: 10.539

View more
  72 in total

1.  The peptidoglycan of Mycobacterium abscessus is predominantly cross-linked by L,D-transpeptidases.

Authors:  Marie Lavollay; Martine Fourgeaud; Jean-Louis Herrmann; Lionel Dubost; Arul Marie; Laurent Gutmann; Michel Arthur; Jean-Luc Mainardi
Journal:  J Bacteriol       Date:  2010-11-19       Impact factor: 3.490

2.  Acute respiratory failure involving an R variant of Mycobacterium abscessus.

Authors:  Emilie Catherinot; Anne-Laure Roux; Edouard Macheras; Dominique Hubert; Moussa Matmar; Luc Dannhoffer; Thierry Chinet; Philippe Morand; Claire Poyart; Beate Heym; Martin Rottman; Jean-Louis Gaillard; Jean-Louis Herrmann
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

3.  Essential engagement of Toll-like receptor 2 in initiation of early protective Th1 response against rough variants of Mycobacterium abscessus.

Authors:  Jong-Seok Kim; Min-Jung Kang; Woo Sik Kim; Seung Jung Han; Hong Min Kim; Ho Won Kim; Kee Woong Kwon; So Jeong Kim; Seung Bin Cha; Seok-Yong Eum; Won-Jung Koh; Sang-Nae Cho; Jong-Hwan Park; Sung Jae Shin
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

4.  Synergistic Efficacy of β-Lactam Combinations against Mycobacterium abscessus Pulmonary Infection in Mice.

Authors:  Elizabeth Story-Roller; Emily C Maggioncalda; Gyanu Lamichhane
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

Review 5.  Macrophage Signaling Pathways in Pulmonary Nontuberculous Mycobacteria Infections.

Authors:  Zohra Prasla; Roy L Sutliff; Ruxana T Sadikot
Journal:  Am J Respir Cell Mol Biol       Date:  2020-08       Impact factor: 6.914

6.  Demonstration of cord formation by rough Mycobacterium abscessus variants: implications for the clinical microbiology laboratory.

Authors:  Alejandro Sánchez-Chardi; Francesc Olivares; Thomas F Byrd; Esther Julián; Cecilia Brambilla; Marina Luquin
Journal:  J Clin Microbiol       Date:  2011-04-13       Impact factor: 5.948

7.  Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation.

Authors:  Audrey Bernut; Jean-Louis Herrmann; Karima Kissa; Jean-François Dubremetz; Jean-Louis Gaillard; Georges Lutfalla; Laurent Kremer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

8.  Deciphering and Imaging Pathogenesis and Cording of Mycobacterium abscessus in Zebrafish Embryos.

Authors:  Audrey Bernut; Christian Dupont; Alain Sahuquet; Jean-Louis Herrmann; Georges Lutfalla; Laurent Kremer
Journal:  J Vis Exp       Date:  2015-09-09       Impact factor: 1.355

9.  Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice.

Authors:  Martin Rottman; Emilie Catherinot; Patrick Hochedez; Jean-François Emile; Jean-Laurent Casanova; Jean-Louis Gaillard; Claire Soudais
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

10.  Mycobacterium abscessus phospholipase C expression is induced during coculture within amoebae and enhances M. abscessus virulence in mice.

Authors:  Jean Claude Bakala N'Goma; Vincent Le Moigne; Nathalie Soismier; Laura Laencina; Fabien Le Chevalier; Anne-Laure Roux; Isabelle Poncin; Carole Serveau-Avesque; Martin Rottman; Jean-Louis Gaillard; Gilles Etienne; Roland Brosch; Jean-Louis Herrmann; Stéphane Canaan; Fabienne Girard-Misguich
Journal:  Infect Immun       Date:  2014-12-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.